Cargando…
Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
Angiogenesis is a characteristic of glioblastoma (GBM), the most fatal and therapeutic-resistant brain tumor. Highly expressed angiogenic cytokines and proliferated microvascular system made anti-angiogenesis treatments a thoroughly plausible approach for GBM treatment. Many trials have proved to be...
Autores principales: | Daneshimehr, Fatemeh, Barabadi, Zahra, Abdolahi, Shahrokh, Soleimani, Masoud, Verdi, Javad, Ebrahimi-Barough, Somayeh, Ai, Jafar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617020/ https://www.ncbi.nlm.nih.gov/pubmed/36259473 http://dx.doi.org/10.22074/cellj.2022.8154 |
Ejemplares similares
-
Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model
por: Abdolahi, Shahrokh, et al.
Publicado: (2021) -
Targeting TRAF3IP2 inhibits angiogenesis in glioblastoma
por: Izadpanah, Amin, et al.
Publicado: (2022) -
Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury
por: Namini, Mojdeh Salehi, et al.
Publicado: (2023) -
3-Dimensional Model to Study Apoptosis Induction of Activated Natural Killer Cells Conditioned Medium Using Patient-Derived Colorectal Cancer Organoids
por: Parseh, Benyamin, et al.
Publicado: (2022) -
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma
por: Hosseinzadeh, Faezeh, et al.
Publicado: (2019)